Bennett Leventhal to Treatment Outcome
This is a "connection" page, showing publications Bennett Leventhal has written about Treatment Outcome.
Connection Strength
0.066
-
A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa. Arch Gen Psychiatry. 2007 Sep; 64(9):1049-56.
Score: 0.032
-
A pharmacogenetic study of escitalopram in autism spectrum disorders. Autism Res. 2010 Feb; 3(1):1-7.
Score: 0.009
-
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry. 2009 Oct; 166(10):1141-9.
Score: 0.009
-
A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):517-24.
Score: 0.007
-
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2001 Jun; 40(6):658-65.
Score: 0.005
-
Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study. J Clin Oncol. 1994 Jul; 12(7):1383-9.
Score: 0.003